Table 23Clinical evidence summary table: pro formas or structured charts

Number of studiesStudy designsPro forma typesFeatures of new pro formaEffectiveness of new pro formaEffectiveness-prevention of allergic reactionsQuality(a)
91 RCT
5 studies with before-and-after study components
1 retrospective data review with prospective patient interview
2 prospective review of referral letters and admission records
2 studies assessed a preoperative assessment form for patients undergoing surgical procedures
1 study assessed a standardised medication chart for inpatients
2 studies assessed a formal assessment pro forma with a clearly designated allergy section for i) use in paediatric inpatient unit and ii) within a department of psychiatry.
1 study assessed a structured penicillin allergy assessment form for patients attending a day surgery unit at a hospital
1 study assessed a structured pro forma for communication between GP practices and emergency departments
Making patient info more visible
Giving prompts for clinicians to provide certain info, including allergy
Allowing clinicians to provide detailed history of previous reactions
Clearly designating an allergy-only section
For communication between GPs and EDs: the front side was for GPs and the reverse side was for EDs to provide outcomes of the referred case
Standardised to be consistent with other forms used in local area
Positive outcomes observed
Reduction in prescribing errors
Increase in compliance with documentation of allergy status in some charts but not others
Increase in referral letters that include allergy information
Increase in accuracy of allergy identification
Increase in the number of times allergy components were included/completed
Negative outcomes observed
Increase in adverse drug reactions
No overall difference in quality of information between new pro forma or previous version
Decrease in frequency of recording of allergy by anaesthetists
One study reported the changes in rates of reactions:
It was described that drug selection (previous ADR) was reduced from 21/9772 (0.21%) to 9/10352 (0.08%)
VERY LOW
a

The majority of evidence stems from study designs with major risks of bias, such as retrospective and before-after designs. The method of analysis was also often not adequately described and did not adjust for any differences in group characteristics.

From: 9, Documenting and sharing information with other healthcare professionals

Cover of Drug Allergy
Drug Allergy: Diagnosis and Management of Drug Allergy in Adults, Children and Young People.
NICE Clinical Guidelines, No. 183.
National Clinical Guideline Centre (UK).
Copyright © National Clinical Guideline Centre, 2014.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.